Statin Users Show LDL Doesn't Come Close to Telling Whole Story of ASCVD

(MedPage Today) -- NEW ORLEANS -- It was inflammation, not cholesterol per se, that was the bigger contributor to residual cardiovascular risk on statin therapy, according to a large meta-analysis of the PROMINENT, REDUCE-IT, and STRENGTH trials...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news